Bolte Axel - Insider Non-Derivative Transactions at Inozyme Pharma, Inc. (INZY) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Mar 31, 2023, Bolte Axel's relationship to Inozyme Pharma, Inc. (INZY) is Director, and currently has 266,696 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other INZY insiders.
Data Source: SEC.
Bolte Axel - Insider Non-Derivative Transactions at INZY
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Apr 1, 2023 | Acquisition -- (Common Stock) | 4806 | 2.21 | 266696 |